A 12 Week Physical Training Programme for Patients With Chronic Obstructive Pulmonary Disease

NCT ID: NCT00744484

Last Updated: 2022-03-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-02-29

Study Completion Date

2010-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether water based or land based group training is more effective for people with COPD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

COPD is a more common diagnosis today compared to 20 years ago, and the group is growing fast. The suffering caused by COPD and the financial cost to society is on the increasing. The principal causes of COPD are smoking and inactivity. So far it is poorly understood wich form of exercise is the most effective in training this condition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

B1

B1 - training in water

Group Type EXPERIMENTAL

Training in water

Intervention Type BEHAVIORAL

45 minutes interval training in water, submaximal intensity, twice a week

S1

S1 - training on land

Group Type EXPERIMENTAL

Training on land

Intervention Type BEHAVIORAL

45 minutes interval training on land, submaximal intensity, twice a week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Training in water

45 minutes interval training in water, submaximal intensity, twice a week

Intervention Type BEHAVIORAL

Training on land

45 minutes interval training on land, submaximal intensity, twice a week

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* COPD GOLD II
* Not taking part in physical activity during the last year

Exclusion Criteria

* COPD GOLD I, III, IV
* Pain in the legs that make activity difficult
Minimum Eligible Age

50 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Helse Nord-Trøndelag HF

OTHER

Sponsor Role collaborator

Nord-Trøndelag University College

OTHER

Sponsor Role collaborator

Norwegian University of Science and Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thor Naustdal, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital of Levanger / NTNU ISB

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Levanger Hosp

Levanger, Nord-Trøndelag, Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17117

Identifier Type: OTHER

Identifier Source: secondary_id

4.2007.679 (REK)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.